Latest Breaking News On - Biolinerx ltd - Page 9 : comparemela.com

BioLineRx Ltd (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2023 Financial Results Conference Call. All participants are presently in a listen-only mode.

United statesGloria biosciencesJoe pantginisElla soraniPhil serlinJohn laceyColumbia universityUs researchOil producing countriesExchange commissionCorporate communicationsAmerican societyWashington university school of medicineBiolinerx ltdCall transcript novemberBiolinerx third quarter

BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M S Q Ventures

M.S.Q. Ventures (MSQ) is pleased to announce that its client,BioLineRx Ltd.(BioLineRx) (NASDAQ/TASE: BLRX), has entered into an exclusive license agreement withGuangzhou Gloria Biosciences Co., Ltd.(GloriaBio) and an associated investor for the

Philip serlinJiman zhuBiolinerx ltdGuangzhou gloria biosciences co ltdChief executive officer

MSQ Ventures: BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M S Q Ventures

MSQ Ventures: BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M S Q Ventures
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Philip serlinJiman zhuGuangzhou gloria biosciences co ltdBiolinerx ltdChief executive officerNew york based

BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M S Q Ventures

BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M S Q Ventures
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Philip serlinJiman zhuBiolinerx ltdGuangzhou gloria biosciences co ltdChief executive officerNew york based

Short Interest in BioLineRx Ltd (NASDAQ:BLRX) Drops By 59 8%

BioLineRx Ltd. (NASDAQ:BLRX – Get Free Report) saw a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 1,030,000 shares, a drop of 59.8% from the September 30th total of 2,560,000 shares. Based on an average daily volume of 1,200,000 shares, the days-to-cover ratio is […]

Geneos wealth management incRenaissance technologiesEnvestnet asset management incBiolinerx ltdAtria wealth solutions incGet free reportWealth managementAsset managementAtria wealth solutionsLinerx ltdBiolinerx dailyNasdaq blrx